Logo do repositório
 
Publicação

Caffeine, adenosine receptors, and synaptic plasticity

dc.contributor.authorCostenla, Ana Rita
dc.contributor.authorCunha, Rodrigo A.
dc.contributor.authorDe Mendonça, Alexandre
dc.date.accessioned2012-05-09T13:23:15Z
dc.date.available2012-05-09T13:23:15Z
dc.date.issued2010
dc.descriptionCopyright ©2012 IOS Press All rights reserved.por
dc.description.abstractFew studies to date have looked at the effects of caffeine on synaptic plasticity, and those that did used very high concentrations of caffeine, whereas the brain concentrations attained by regular coffee consumption in humans should be in the low micromolar range, where caffeine exerts pharmacological actions mainly by antagonizing adenosine receptors. Accordingly, rats drinking caffeine (1 g/L) for 3 weeks, displayed a concentration of caffeine of circa 22 μM in the hippocampus. It is known that selective adenosine A1 receptor antagonists facilitate, whereas selective adenosine A2A receptor antagonists attenuate, long term potentiation (LTP) in the hippocampus. Although caffeine is a non-selective antagonist of adenosine receptors, it attenuates frequency-induced LTP in hippocampal slices in a manner similar to selective adenosine A2A receptor antagonists. These effects of low micromolar concentration of caffeine (30 μM) are maintained in aged animals, which is important when a possible beneficial effect for caffeine in age-related cognitive decline is proposed. Future studies will still be required to confirm and detail the involvement of A1 and A2A receptors in the effects of caffeine on hippocampal synaptic plasticity, using both pharmacological and genetic approaches.eng
dc.description.sponsorshipThe work was supported by Fundação para a Ciência e Tecnologia and Fundação Oriente.eng
dc.identifier.citationJournal of Alzheimer’s Disease 20 (2010) S25–S34por
dc.identifier.issn1387-2877
dc.identifier.urihttp://hdl.handle.net/10451/6253
dc.identifier.uriDOI 10.3233/JAD-2010-091384
dc.identifier.urihttp://iospress.metapress.com/content/77r8428t6g2j81pl/fulltext.pdf
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherIOS Presspor
dc.subjectA2A receptorseng
dc.subjectAdenosineeng
dc.subjectCaffeineeng
dc.subjectLong-term potentiationeng
dc.subjectHippocampuseng
dc.subjectSynaptic plasticityeng
dc.titleCaffeine, adenosine receptors, and synaptic plasticityeng
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPageS34por
oaire.citation.startPageS25por
oaire.citation.titleJournal of Alzheimer's Diseasepor
person.familyNamede Mendonça
person.givenNameAlexandre
person.identifier.ciencia-id1615-41B4-0848
person.identifier.orcid0000-0002-0488-1453
person.identifier.scopus-author-id7003320823
rcaap.rightsopenAccesspor
rcaap.typearticlepor
relation.isAuthorOfPublication53ca3547-99ce-4b68-9330-7879a54c47b7
relation.isAuthorOfPublication.latestForDiscovery53ca3547-99ce-4b68-9330-7879a54c47b7

Ficheiros

Principais
A mostrar 1 - 1 de 1
A carregar...
Miniatura
Nome:
Artigo.pdf
Tamanho:
557.04 KB
Formato:
Adobe Portable Document Format
Licença
A mostrar 1 - 1 de 1
Miniatura indisponível
Nome:
license.txt
Tamanho:
1.2 KB
Formato:
Item-specific license agreed upon to submission
Descrição: